Crystallographic approach to fragment-based hit discovery against Schistosoma mansoni purine nucleoside phosphorylase. 2021

Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
Laboratório de Biofísica Molecular, Departamento de Biologia Celular, Universidade de Brasília, Brasília, DF 70910-900, Brazil.

Several Schistosoma species cause Schistosomiasis, an endemic disease in 78 countries that is ranked second amongst the parasitic diseases in terms of its socioeconomic impact and human health importance. The drug recommended for treatment by the WHO is praziquantel (PZQ), but there are concerns associated with PZQ, such as the lack of information about its exact mechanism of action, its high price, its effectiveness - which is limited to the parasite's adult form - and reports of resistance. The parasites lack the de novo purine pathway, rendering them dependent on the purine salvage pathway or host purine bases for nucleotide synthesis. Thus, the Schistosoma purine salvage pathway is an attractive target for the development of necessary and selective new drugs. In this study, the purine nucleotide phosphorylase II (PNP2), a new isoform of PNP1, was submitted to a high-throughput fragment-based hit discovery using a crystallographic screening strategy. PNP2 was crystallized and crystals were soaked with 827 fragments, a subset of the Maybridge 1000 library. X-ray diffraction data was collected and structures were solved. Out of 827-screened fragments we have obtained a total of 19 fragments that show binding to PNP2. Fourteen of these fragments bind to the active site of PNP2, while five were observed in three other sites. Here we present the first fragment screening against PNP2.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000072756 Protein Conformation, alpha-Helical A secondary structure of proteins that is a right-handed helix or coil, where each amino (N-H) group of the peptide backbone contributes a hydrogen bond to the carbonyl(C alpha-Helical Conformation, Protein,alpha-Helical Protein Conformation,alpha-Helical Structures,alpha-Helices,alpha-Helix,Conformation, Protein alpha-Helical,Conformation, alpha-Helical Protein,Conformations, Protein alpha-Helical,Conformations, alpha-Helical Protein,Protein Conformation, alpha Helical,Protein Conformations, alpha-Helical,alpha Helical Conformation, Protein,alpha Helical Protein Conformation,alpha Helical Structures,alpha Helices,alpha Helix,alpha-Helical Conformations, Protein,alpha-Helical Protein Conformations,alpha-Helical Structure
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012550 Schistosoma mansoni A species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis. Schistosoma mansonus,mansonus, Schistosoma

Related Publications

Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
June 2003, Acta crystallographica. Section D, Biological crystallography,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
May 2013, Analytical and bioanalytical chemistry,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
January 2011, Journal of synchrotron radiation,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
October 2005, Journal of molecular biology,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
February 2010, Bioorganic & medicinal chemistry,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
January 2013, Biomeditsinskaia khimiia,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
November 2022, Journal of biomolecular structure & dynamics,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
July 2010, Bioorganic & medicinal chemistry,
Muhammad Faheem, and Napoleão Fonseca Valadares, and José Brandão-Neto, and Dom Bellini, and Patrick Collins, and Nicholas M Pearce, and Louise Bird, and Juliana Roberta Torini, and Raymond Owens, and Humberto DMuniz Pereira, and Frank Von Delft, and João Alexandre Ribeiro Gonçalves Barbosa
November 2004, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!